Aaron Philip Mitchell

29PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyHaematological tumoursNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Feb 03, 2026
Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.

Michael S Leapman, Jessica B Long, Sarah Westvold

|Dec 02, 2025
What Is the Cost Impact of Second Opinions in Oncology? A Retrospective Review.

Benjamin R Roman, Allison Lipitz-Snyderman, Susan Chimonas

|Nov 07, 2025
Pricing Trends and Overlapping Indications of Checkpoint Inhibitors for Cancer Treatment.

Jeddeo M Paul, Aaron P Mitchell, Aaron S Kesselheim

|Nov 05, 2025
Provider billing margin and cancer treatment selection: population based cohort study.

Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza

|Nov 03, 2025
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer.

Aaron P Mitchell, Andrew Salner, Paul Palyca

|Sep 16, 2025
Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses.

Issam S Hamadeh, Lisa Modelevsky, Amelia Chan

Pageof 5